文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

排名前 100 的肾细胞癌高被引文献：文献计量学分析。

Top 100 most-cited articles on renal cell carcinoma: A bibliometric analysis.

机构信息

First Clinical Medical College, Shanxi Medical University, Taiyuan, China.

Department of Urology, The First Hospital of Shanxi Medical University, Taiyuan, China.

出版信息

Medicine (Baltimore). 2023 Feb 10;102(6):e32926. doi: 10.1097/MD.0000000000032926.

DOI:10.1097/MD.0000000000032926
PMID:36820552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9907913/
Abstract

BACKGROUND: To analyze the top 100 most-cited articles on renal cell carcinoma (RCC) using bibliometric methods based on the Web of Science core collection database and to explore the research status, hotspots, and emerging trends in RCC. METHODS: The literature on RCC was searched in the Web of Science core collection database using a specific search strategy, and the types of literature were limited to articles and reviews, with no restrictions to language and publication date. The top 100 articles with the highest number of citations were extracted after the manual screening. The publication year, the number of citations, authors, country, institution, journal, and keywords of these articles were collected and analyzed. Descriptive statistics and visual analysis were performed using Microsoft Excel, VOSviewer, CiteSpace, R, and SPSS. RESULTS: The number of citations of the top 100 articles varied from 541 to 4530, with a median citation count of 807.5, and the citation rates ranged from 13.8 to 448.4 citations per year. Motzer RJ (n = 22), Escudier B (n = 13), Rini BI (n = 13), and Hutson TE (n = 11) were major contributors to this research area, with Motzer RJ publishing 16 articles as the first author. The US (n = 73), France (n = 5), Canada (n = 4), and Sweden (n = 4) were the leading countries for RCC studies. MEMORIAL SLOAN KETTERING CANCER CENTER (n = 22) was the institution with the highest number of publications. These 100 articles were derived from 24 journals, and the New England Journal of Medicine had the largest number of articles published (n = 18, impact factor = 91.245). The keyword co-occurrence network analysis showed that research hotspots in this field included molecular mechanisms of RCC development and progression, surgical treatment, targeted drug-related clinical trials, and immunotherapy. CONCLUSION: We analyzed the top 100 articles with the highest number of citations in the field of RCC and identified the influential authors, countries, institutions, and journals in this field. This study also presented the current research status, hotspots, and future trends in RCC.

摘要

背景： 基于 Web of Science 核心合集数据库，采用文献计量学方法分析肾细胞癌（RCC）领域被引频次最高的前 100 篇文献，探讨 RCC 的研究现状、热点和新兴趋势。

方法： 在 Web of Science 核心合集数据库中使用特定的检索策略检索 RCC 文献，文献类型限定为文章和综述，不限制语言和出版日期。经过人工筛选，提取被引频次最高的前 100 篇文章。收集并分析这些文章的出版年份、被引频次、作者、国家、机构、期刊和关键词。使用 Microsoft Excel、VOSviewer、CiteSpace、R 和 SPSS 进行描述性统计和可视化分析。

结果： 前 100 篇文章的被引频次从 541 次到 4530 次不等，中位数为 807.5 次，年被引率为 13.8 次到 448.4 次。Motzer RJ（n = 22）、Escudier B（n = 13）、Rini BI（n = 13）和 Hutson TE（n = 11）是该研究领域的主要贡献者，Motzer RJ 作为第一作者发表了 16 篇文章。美国（n = 73）、法国（n = 5）、加拿大（n = 4）和瑞典（n = 4）是 RCC 研究的主要国家。发表文章数量最多的机构是 Memorial Sloan Kettering Cancer Center（n = 22）。这 100 篇文章来自 24 种期刊，其中 New England Journal of Medicine 发表的文章最多（n = 18，影响因子 = 91.245）。关键词共现网络分析表明，该领域的研究热点包括 RCC 发生发展的分子机制、手术治疗、靶向药物相关临床试验和免疫治疗。

结论： 我们分析了 RCC 领域被引频次最高的前 100 篇文献，确定了该领域有影响力的作者、国家、机构和期刊。本研究还呈现了 RCC 的当前研究现状、热点和未来趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/2034d1795146/medi-102-e32926-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/2765ccd0346e/medi-102-e32926-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/073d4edae34b/medi-102-e32926-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/ced0d389dc74/medi-102-e32926-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/a55293aef1e9/medi-102-e32926-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/5bc49dedc35e/medi-102-e32926-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/4cc11111a6ba/medi-102-e32926-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/d71af00a6f54/medi-102-e32926-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/fab7f503d4e6/medi-102-e32926-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/e695b6d6d0d0/medi-102-e32926-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/2034d1795146/medi-102-e32926-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/2765ccd0346e/medi-102-e32926-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/073d4edae34b/medi-102-e32926-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/ced0d389dc74/medi-102-e32926-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/a55293aef1e9/medi-102-e32926-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/5bc49dedc35e/medi-102-e32926-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/4cc11111a6ba/medi-102-e32926-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/d71af00a6f54/medi-102-e32926-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/fab7f503d4e6/medi-102-e32926-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/e695b6d6d0d0/medi-102-e32926-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e07/9907913/2034d1795146/medi-102-e32926-g010.jpg

相似文献

[1]
Top 100 most-cited articles on renal cell carcinoma: A bibliometric analysis.

Medicine (Baltimore). 2023-2-10

[2]
Evolutions in the management of non-small cell lung cancer: A bibliometric study from the 100 most impactful articles in the field.

Front Oncol. 2022-8-17

[3]
Current perspectives and trends of CD39-CD73-eAdo/A2aR research in tumor microenvironment: a bibliometric analysis.

Front Immunol. 2024

[4]
Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Bibliometric Analysis via CiteSpace from 2000 to 2022.

Urol Int. 2023

[5]
Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.

Front Biosci (Landmark Ed). 2022-8-31

[6]
The 100 top-cited articles in diabetic kidney disease: a bibliometric analysis.

Ren Fail. 2021-12

[7]
Insight into the research history and trends of total anomalous pulmonary venous connection: a bibliometric analysis.

J Cardiothorac Surg. 2024-5-11

[8]
Knowledge mapping and research hotspots of immunotherapy in renal cell carcinoma: A text-mining study from 2002 to 2021.

Front Immunol. 2022

[9]
The Top 100 Cited Articles Focusing on Acute Lung Injury and ARDS: Bibliometric and Visualization Analyses.

Respir Care. 2024-7-24

[10]
Bibliometric and visualized analysis of the top-100 highly cited articles on immunotherapy for endometrial cancer.

Medicine (Baltimore). 2023-7-7

引用本文的文献

[1]
Synthetic data as an investigative tool in hypertension and renal diseases research.

World J Methodol. 2025-3-20

[2]
Renal cell carcinoma and macrophage research: A bibliometric analysis (2004-2023).

Medicine (Baltimore). 2024-12-13

[3]
The bibliometric analysis of most cited 100 papers in anesthesia-induced neurotoxicity.

Medicine (Baltimore). 2023-12-1

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索